U.S. Food Stock News

Why Gen Digital is on investors’ radar Gen Digital (GEN) has drawn attention after recent trading that left the share price at US$19.91. With a market value of about US$12.4b, investors are weighing the stock’s recent performance against its current fundamentals. See our latest analysis for Gen Digital. Recent trading reflects that momentum has softened, with a 7 day share price return of 5.29% compared with a 90 day share price return of 20.98% and a 1 year total shareholder return of...

Earlier in April 2026, Hamilton Lane announced a wide slate of senior promotions to Managing Director and Principal across investment, legal, finance, operations, and client-facing teams, alongside new hires leading U.S. national sales and UK/European direct credit. By elevating leaders in evergreen sales, secondary investments, and direct credit, the firm is signaling a deeper push into scaled private wealth distribution and European private credit capabilities. Now we’ll examine how this...

Wondering if FirstCash Holdings at around US$208 a share still offers value, or if most of the upside is already priced in. The stock has returned 2.6% over the last week, 8.3% over the past month, 32.7% year to date and 73.0% over the last year, with 3 year and 5 year returns of 125.1% and 207.7% respectively. Recent coverage has focused on FirstCash Holdings' role in consumer finance and how its pawn and retail operations fit into broader credit conditions. This helps frame expectations...

Synchrony Financial (SYF) opened 2026 with Q1 revenue of US$2,363 million and basic EPS of US$2.32, setting the tone for its latest earnings update. The company has seen revenue move from US$2,227 million in Q1 2025 to US$2,363 million in Q1 2026, while trailing twelve month EPS sits at US$10.12 on net income of US$3,517 million. This gives investors a clear read on how profitability is tracking into the new year. With margins currently framed by this earnings run rate, the quarter gives...

Turning Point Brands (TPB) is back in focus after its FRE Nicotine Pouches brand entered a multiyear partnership with TKO Group Holdings, gaining visibility across UFC, Zuffa Boxing, PBR, and other high-attendance sports properties. See our latest analysis for Turning Point Brands. Despite the FRE partnership news, recent trading has been weak, with a 40.18% 90 day share price return decline and a 35.97% year to date share price return decline. However, the 3 year total shareholder return of...

Peoples Bancorp (PEBO) just paired a quarterly earnings beat with a higher cash dividend, a combination that often sharpens investor focus on both the income profile and underlying business performance. See our latest analysis for Peoples Bancorp. At a share price of $34.28, Peoples Bancorp has paired a 7.12% 1 month share price return with a 27.24% 1 year total shareholder return. This suggests momentum has been building as investors weigh the earnings beat, higher dividend and lower net...

Some investors may be wondering if Par Pacific Holdings at around US$61.56 is still offering value, or if most of the opportunity is already priced in. The stock has had a mixed short term patch, with a 2.7% decline over 7 days and a flat 0.3% move over 30 days, but sits on returns of 71.9% year to date and 341.0% over the past year. Recent coverage has focused on Par Pacific Holdings as an energy name that has attracted attention after strong share price performance and increased interest...

If you are wondering whether Intel's current share price still offers value after a strong run, the key is to look past the headlines and into what the numbers imply about today's valuation. At a last close of US$66.26, Intel has posted returns of 3.8% over 7 days, 51.0% over 30 days, 68.3% year to date, 239.6% over 1 year and 135.1% over 3 years, with a 5 year return of 25.7%. This naturally raises questions about how much optimism is already reflected in the price. Recent news coverage has...

Wondering if Axcelis Technologies at around US$133 per share still offers value, or if most of the upside may already be reflected in the price. The stock has posted returns of 17.8% over 7 days, 57.8% over 30 days, 54.7% year to date and 195.3% over 1 year. This naturally raises questions about potential growth and shifts in perceived risk. These sharp moves sit against a backdrop of ongoing investor interest in semiconductor equipment providers and how they fit into longer term chip...

In mid-April 2026, NetApp announced an expanded four-year Enterprise Agreement with Google Cloud to deploy its AFF, StorageGRID, and Trident storage solutions within Google Distributed Cloud air-gapped, a sovereign, fully disconnected cloud platform delivered by World Wide Technology to support sensitive, regulated workloads. This collaboration positions NetApp at the center of secure, AI-enabled private cloud deployments, enabling organizations to run Gemini-powered generative AI...

Peoples Bancorp of North Carolina (PEBK) opened 2026 with Q1 revenue of US$21.0 million and basic EPS of US$0.83, supported by trailing twelve month revenue of US$89.9 million and EPS of about US$3.75 as profitability strengthened over the past year. The bank has seen trailing EPS move from about US$3.08 to roughly US$3.75 over the last six reported quarters, while net income over the same trailing period reached US$19.9 million. This sets up the latest result against an earnings profile that...

AMC Robotics (AMCI) has just wrapped up FY 2025 with Q4 revenue of US$1.3 million and a basic EPS loss of US$0.52, while trailing twelve month figures show revenue of US$6.0 million and a basic EPS loss of US$1.36 alongside a reported 41.4% revenue decline over the year. Over the past few reported periods, quarterly revenue has ranged from US$1.3 million to US$3.2 million and basic EPS has swung between a profit of US$0.15 and a loss of US$0.52, underscoring how volatile the earnings line has...

On April 13, 2026, CG Oncology, Inc. appointed Jim DeTore as Chief Financial Officer after he had served as Interim Principal Financial and Accounting Officer since November 2025 and previously held senior finance roles at several biotechnology companies, including Neurogastrx, Proteostasis Therapeutics, and Bluebird Bio. This appointment adds long-tenured biotech financial leadership at a time when CG Oncology’s oncolytic immunotherapy program for bladder cancer is attracting increased...

Ciena (NYSE:CIEN) is partnering with Lightstorm to upgrade the Japan, Guam, Australia submarine cable system with advanced optical networking technology. The project focuses on the Tokyo to Sydney route, where capacity is set to be quadrupled to support heavier data traffic. The upgraded system is intended to serve cloud and AI workloads that rely on high performance international connectivity. Ciena comes into this agreement with Lightstorm after a period of very strong share price...

Critical Metals Corp. recently entered into a securities purchase agreement to issue 5,999,998 ordinary shares at US$10.00 each, raising US$59,999,980 through a Regulation D private placement that was expected to close on or about April 22, 2026. This sizeable capital injection via a private placement can influence how investors think about Critical Metals’ funding capacity, project pipeline, and future dilution risk. We’ll now examine how this nearly US$60 million private placement shapes...

Southern First Bancshares (SFST) opened Q1 2026 with total revenue of US$32.5 million and basic EPS of US$1.21, while trailing 12 month revenue sat at US$121.9 million and EPS at US$4.31 off net income of US$35.0 million. Over the past few quarters, revenue has moved from US$25.7 million in Q1 2025 to US$31.2 million in Q4 2025 and US$32.5 million in Q1 2026. Quarterly EPS over the same stretch has run from US$0.65 to US$1.23 and now US$1.21, highlighting higher earnings, a 28.7% trailing net...

TSMC’s recent performance in focus Taiwan Semiconductor Manufacturing (NYSE:TSM) has been drawing attention after an 11.8% monthly return and a 12.9% gain over the past 3 months, prompting investors to reassess its recent share performance. See our latest analysis for Taiwan Semiconductor Manufacturing. At a share price of $368.08, the stock has a 30 day share price return of 11.8% and a year to date share price return of 15.2%, while the 1 year total shareholder return is 145.5%, suggesting...

Earlier in April 2026, Goldman Sachs issued a constructive outlook on Permian Resources ahead of earnings, citing the company’s pure-play Delaware Basin focus, execution record, and emphasis on incremental capital and cost efficiencies. The bank also highlighted Permian Resources’ plans to expand marketing efforts in 2026 to improve natural gas realizations despite ongoing Waha pricing pressure, underscoring management’s attention to pricing quality rather than just production volumes. We’ll...

Braze recently reported quarterly results showing 27.9% year-on-year revenue growth, beating analyst expectations on both billings and EBITDA for the period. This outperformance against consensus forecasts highlights how Braze’s execution and customer engagement platform traction are influencing current expectations for the business. We’ll now examine how this stronger-than-expected revenue and EBITDA performance may influence Braze’s existing investment narrative and future...

Wondering if Shopify at around US$131 per share still offers value or if most of the upside is already priced in? This article focuses squarely on what the current market price might be implying. The stock has returned 2.9% over the last week and 8.3% over the last month, while year to date it is down 16.6% and up 44.2% over the last year, with a 3 year return of 182.8% and 5 year return of 1.7%. Recent coverage has focused on Shopify's role as a major e commerce platform and its position in...

IDEAYA Biosciences (NasdaqGS:IDYA) has entered a clinical collaboration with AstraZeneca to study IDE849, a DLL3 TOP1 antibody drug conjugate. The program will evaluate IDE849 in combination with Imfinzi in extensive stage small cell lung cancer and other DLL3 upregulated tumors. For readers tracking IDEAYA mainly through its uveal melanoma drug darovasertib, this collaboration with AstraZeneca broadens the story. The company, trading at $31.83, has delivered a 70.9% return over the past...

Wintrust Financial (WTFC) opened 2026 with Q1 revenue of US$682.4 million and basic EPS of US$3.26, while trailing twelve month revenue stood at US$2.7 billion and EPS at US$12.10. This gives investors a clear snapshot of both the latest quarter and the broader earnings run rate. Over the past year, revenue has moved from US$2.3 billion to US$2.7 billion and trailing EPS has shifted from US$10.47 to US$12.10, setting the backdrop for how the market may read this earnings print. With a...

If you are wondering whether Verizon Communications at around US$46.27 offers enough value for the risks involved, this article breaks down what the current price might imply. The stock is up 1.7% over the last 7 days and 14.3% over the past year, while the 30 day return is a 7.4% decline. The 3 year return stands at 51.8% and the 5 year return at 12.0%. Recent coverage has focused on Verizon Communications as a core US telecom player, with attention on its network investments, competitive...

Wondering if Hubbell's share price still offers value after a strong run, or if most of the opportunity is already reflected in the current US$549.11 level. Hubbell has posted returns of 0.6% over the last 7 days, 15.4% over the past month, 18.6% year to date, 63.3% over 1 year, 120.3% over 3 years and 206.6% over 5 years, which naturally raises questions about how the current price stacks up against fundamentals. These moves sit against a backdrop of ongoing interest in companies involved...